← Eichor
Study identifier: NCT07332858 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

Condition: Malignant Pleural Effusions (Mpe) · Non Small Cell Lung Cancer  ·  Sponsor: Gang Hou

PhasePhase 1/Phase 2
Planned participants105
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study aims to evaluate the safety of intrapleural injection of TolueneSulfonamide in patients with malignant pleural effusion and to explore its potential effectiveness.

This description comes directly from the study's public registry record.

Talk to the study team

Gang Hou, PhD  ·  +86 13840065481  ·  hougangcmu@163.com

Liwei Liao, PhD  ·  +86 18090027855  ·  291633325@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

China-Japan Friendship HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07332858